Pulmonary artery perfusion with HTK solution prevents lung injury in infants after cardiopulmonary bypass.
Li
Jian-an
JA
Pediatric Cardiac Surgery Center, Fuwai Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100037, China.
Liu
Ying-long
YL
Liu
Jin-Ping
JP
Li
Xiao-feng
XF
D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006330:Heart Defects, Congenital / Q000097:blood / Q000601:surgery; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood; D016753:Interleukin-10 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D055370:Lung Injury / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D019188:Organ Preservation Solutions / Q000627:therapeutic use*; D019007:P-Selectin / Q000097:blood; D010477:Perfusion / Q000379:methods*; D011651:Pulmonary Artery
D015850:Interleukin-6; D016209:Interleukin-8; D019188:Organ Preservation Solutions; D019007:P-Selectin; D018799:Intercellular Adhesion Molecule-1; D016753:Interleukin-10